Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial

Gholamreza Roshandel(Golestan University), Reza Malekzadeh(Shiraz University of Medical Sciences), Farin Kamangar, Tom Marshall(University of Birmingham), Mohammad Naemi-Tabiei(Golestan University), Behrooz Navabakhsh(Shariati Hospital), Nizal Sarrafzadegan(Isfahan University of Medical Sciences), Mahdi Nalini(Tehran University of Medical Sciences), Kar Keung Cheng, Paolo Boffetta(Centre International de Recherche sur le Cancer), Abdolreza Fazel(Golestan University), Karla Hemming(University of Birmingham), Fatemeh Malekzadeh(Tehran University of Medical Sciences), G. Neil Thomas(University of Birmingham), Arash Etemadi, Masoud Khoshnia(Shariati Hospital), Hossein Poustchi(Shariati Hospital), Akram Pourshams, Noushin Mohammadifard(Isfahan University of Medical Sciences), Shahin Merat(Non-Communicable Diseases Research Center), Masoumeh Sadeghi(Isfahan University of Medical Sciences), Masoud Majed(Mayo Clinic), Mohammad R. Ostovaneh(Tehran University of Medical Sciences), Paul Brennan(Centre International de Recherche sur le Cancer), Abdolsamad Gharavi(Shariati Hospital), Alireza Nateghi(Tehran University of Medical Sciences)
The Lancet
August 1, 2019
Cited by 284


Related Papers